Q4 2024 Alignment Healthcare Inc Earnings Call Transcript
Key Points
- Alignment Healthcare Inc (ALHC) achieved a 59% increase in health plan membership, surpassing initial guidance by over 25,000 members.
- Total revenue for the fourth quarter of 2024 grew by approximately 51% year-over-year, reaching $701 million.
- The company reported its first year of adjusted EBITDA profitability as a public company, with a positive adjusted EBITDA of $1 million.
- ALHC's ex-California markets experienced over 100% growth, with Nevada achieving over 10,000 members.
- The company is well-positioned for future growth, with 98% of members in plans rated 4 stars or above for the 2026 payment year, significantly outperforming the industry average.
- The company faces challenges from the second phase-in of the V28 risk model changes, which could impact margins.
- There is a modestly higher utilization volume expectation due to the mix of membership, which could affect profitability.
- ALHC's adjusted SG&A expenses increased by 23% year-over-year, which may impact operating leverage.
- The company anticipates changes in MBR seasonality due to the Inflation Reduction Act, potentially affecting financial performance.
- ALHC's growth strategy involves significant investment in clinical resources, which could increase operational costs.
Good afternoon, and welcome to Alignment Healthcare's fourth-quarter 2024 earnings conference call and webcast. (Operator Instructions) Please note that this event is being recorded. Leading today's call are John Kao, Founder and CEO; and Thomas Freeman, Chief Financial Officer. Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act.
These forward-looking statements are subject to risks and uncertainties and reflect our current expectations based on beliefs, assumptions and information currently available to us. Descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the Risk Factors section of our annual report on Form 10-K for the fiscal year ended December 31, 2024. Although we believe our expectations are reasonable and undertake no obligation to revise any statements to reflect changes that occur after this call. In addition,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
